Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MD › BALTIMORE › THE JOHNS HOPKINS HOSPITAL

THE JOHNS HOPKINS HOSPITAL

NPI: 1578597993 · BALTIMORE, MD 21287 · General Acute Care Hospital · NPI assigned 07/10/2006

$19.90M
Total Medicaid Paid
753,076
Total Claims
549,502
Beneficiaries
316
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMILLER, REDONDA (PRESIDENT)
NPI Enumeration Date07/10/2006

Related Entities

Other providers sharing the same authorized official: MILLER, REDONDA

ProviderCityStateTotal Paid
THE JOHNS HOPKINS HOSPITAL BALTIMORE MD $6.68M
THE JOHNS HOPKINS HOSPITAL BALTIMORE MD $139K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 163,159 $6.98M
2019 134,081 $3.30M
2020 71,925 $1.85M
2021 97,386 $2.24M
2022 114,610 $2.29M
2023 99,032 $1.94M
2024 72,883 $1.32M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 8,498 7,327 $2.65M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 4,993 4,364 $2.29M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 101,187 78,078 $1.98M
87536 8,265 7,545 $1.83M
G0378 Hospital observation service, per hour 4,624 3,998 $1.66M
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 1,149 994 $859K
99283 Emergency department visit for the evaluation and management, moderate severity 5,153 4,429 $810K
P9016 Red blood cells, leukocytes reduced, each unit 1,668 1,369 $741K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 8,214 5,845 $609K
36512 1,198 1,000 $609K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 5,583 3,384 $482K
80053 Comprehensive metabolic panel 44,771 31,019 $364K
99281 Emergency department visit for the evaluation and management, self-limited or minor 5,536 3,975 $265K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,884 2,727 $256K
J2794 Injection, risperidone (risperdal consta), 0.5 mg 1,194 554 $228K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 6,137 2,628 $210K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,894 1,783 $192K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3,190 1,982 $181K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,789 1,458 $163K
90832 Psychotherapy, 30 minutes with patient 5,360 4,264 $144K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 777 472 $136K
96361 Intravenous infusion, hydration; each additional hour 1,508 893 $127K
90834 Psychotherapy, 45 minutes with patient 3,192 2,622 $113K
36430 512 266 $107K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 41,237 29,510 $107K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,963 1,410 $103K
71046 Radiologic examination, chest; 2 views 5,163 4,568 $94K
88305 Level IV - Surgical pathology, gross and microscopic examination 4,076 3,535 $90K
71260 Computed tomography, thorax, diagnostic; with contrast material 1,900 1,804 $88K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 554 489 $87K
93971 630 572 $85K
87901 173 159 $84K
71275 Computed tomographic angiography, chest, with contrast material 1,274 1,187 $80K
71250 1,361 1,260 $80K
90837 Psychotherapy, 53 minutes with patient 1,578 1,128 $71K
87086 Culture, bacterial; quantitative colony count, urine 3,831 3,284 $70K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 7,407 4,868 $70K
70450 Computed tomography, head or brain; without contrast material 2,510 2,238 $62K
36415 Collection of venous blood by venipuncture 29,102 22,871 $57K
94010 567 431 $56K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 93 83 $56K
87070 1,581 1,254 $53K
97161 800 730 $51K
36591 851 594 $50K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2,336 2,040 $47K
76705 Ultrasound, abdominal, real time with image documentation; limited 417 387 $47K
87340 1,066 941 $46K
80048 Basic metabolic panel (calcium, ionized) 6,150 4,696 $46K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,152 490 $45K
87522 Neg quan hep c or qual rna 692 625 $38K
71045 Radiologic examination, chest; single view 3,256 2,891 $36K
86359 2,316 2,162 $34K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1,969 1,830 $32K
96415 1,044 789 $32K
93922 183 174 $27K
82803 1,798 1,212 $25K
J1200 Injection, diphenhydramine hcl, up to 50 mg 2,531 1,758 $24K
81001 12,154 10,147 $23K
86850 6,094 4,357 $22K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 63 30 $21K
72125 Computed tomography, cervical spine; without contrast material 436 386 $21K
97162 306 265 $20K
C1769 Guide wire 1,630 1,533 $20K
96375 Therapeutic injection; each additional sequential IV push 4,234 2,439 $19K
97597 191 80 $19K
86922 1,276 931 $18K
73030 415 371 $17K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,531 3,184 $17K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2,484 2,320 $17K
86902 150 75 $17K
C9399 Unclassified drugs or biologicals 318 273 $17K
78815 Positron emission tomography (PET) for limited area imaging 28 24 $15K
V2632 Posterior chamber intraocular lens 1,497 1,321 $14K
84484 9,749 5,566 $14K
92083 285 257 $13K
85027 6,354 4,942 $13K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 43 41 $13K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2,115 1,950 $13K
52000 47 42 $12K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 210 190 $12K
74176 Computed tomography, abdomen and pelvis; without contrast material 240 197 $12K
73630 381 334 $12K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,686 2,400 $12K
87077 1,167 959 $12K
83036 Hemoglobin; glycosylated (A1C) 5,011 4,761 $11K
J3535 Drug administered through a metered dose inhaler 486 432 $11K
J2704 Injection, propofol, 10 mg 10,767 6,879 $11K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1,578 731 $11K
87497 46 28 $10K
J3490 Unclassified drugs 8,681 5,272 $10K
J7120 Ringers lactate infusion, up to 1000 cc 8,580 6,755 $10K
92557 320 296 $10K
90714 377 314 $10K
72082 38 24 $10K
96402 281 248 $10K
73560 362 320 $10K
96367 760 495 $9K
90686 2,740 2,534 $9K
92567 138 125 $9K
93017 266 234 $9K
90670 121 109 $9K
86140 2,066 1,726 $9K
87631 514 476 $8K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit 22 13 $8K
77066 Tomosynthesis, mammo 24 24 $8K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 22 13 $8K
87799 288 240 $8K
77065 Tomosynthesis, mammo 27 26 $7K
93970 40 38 $7K
80061 Lipid panel 4,239 4,033 $7K
86147 160 141 $7K
96401 243 120 $7K
73130 174 146 $7K
J7030 Infusion, normal saline solution , 1000 cc 7,595 5,393 $6K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 655 257 $6K
92133 195 184 $6K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 217 191 $6K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 13,452 7,973 $6K
90732 175 148 $6K
83021 2,176 1,478 $6K
A9270 Non-covered item or service 58,230 17,184 $6K
83880 4,266 3,787 $5K
83605 4,627 3,475 $5K
74183 15 13 $5K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,650 2,547 $5K
J0171 Injection, adrenalin, epinephrine, 0.1 mg 1,997 1,725 $4K
82728 2,531 2,315 $4K
90677 187 177 $4K
97165 78 71 $4K
90662 1,051 990 $4K
90734 99 91 $4K
88307 139 63 $4K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 11,384 8,821 $4K
J1644 Injection, heparin sodium, per 1000 units 4,261 2,483 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg 10,170 7,705 $4K
76377 304 266 $4K
86923 998 666 $4K
87040 194 106 $4K
73502 77 67 $3K
85046 3,255 1,990 $3K
73110 49 44 $3K
J1170 Injection, hydromorphone, up to 4 mg 3,059 1,615 $3K
82105 238 202 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,200 1,959 $3K
74018 26 18 $3K
86780 1,855 1,775 $3K
84439 2,140 1,984 $3K
73610 69 54 $2K
84702 1,628 1,454 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 62 52 $2K
86706 579 519 $2K
J3010 Injection, fentanyl citrate, 0.1 mg 9,041 7,178 $2K
J1050 Injection, medroxyprogesterone acetate, 1 mg 27 27 $2K
J0690 Injection, cefazolin sodium, 500 mg 3,225 2,663 $2K
85610 6,501 5,577 $2K
67028 Intravitreal injection of a pharmacologic agent 15 12 $2K
91320 208 202 $2K
J7042 5% dextrose/normal saline (500 ml = 1 unit) 445 326 $2K
87081 84 65 $2K
87632 54 46 $2K
88142 51 38 $2K
J1815 Injection, insulin, per 5 units 1,080 612 $2K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 445 412 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 640 547 $2K
45380 Colonoscopy, flexible; with biopsy, single or multiple 36 32 $2K
J1631 Injection, haloperidol decanoate, per 50 mg 1,238 801 $2K
84153 1,069 998 $2K
84443 Thyroid stimulating hormone (TSH) 4,698 4,430 $1K
93350 16 13 $1K
86901 5,818 4,226 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg 3,600 2,735 $1K
93325 97 63 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 720 438 $1K
J2270 Injection, morphine sulfate, up to 10 mg 705 489 $1K
80197 2,379 1,655 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,274 3,984 $1K
86803 671 632 $1K
83735 9,136 6,011 $1K
J7799 Noc drugs, other than inhalation drugs, administered through dme 600 366 $1K
84703 816 715 $1K
85730 2,855 2,464 $989.45
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram 93 85 $889.78
J0330 Injection, succinylcholine chloride, up to 20 mg 448 369 $876.52
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 753 702 $852.83
88112 29 26 $814.00
86481 208 197 $796.71
76770 14 14 $785.97
83690 3,921 3,504 $785.56
J7070 Infusion, d5w, 1000 cc 3,176 1,385 $769.41
86900 5,845 4,230 $733.89
J1650 Injection, enoxaparin sodium, 10 mg 310 179 $733.88
J3475 Injection, magnesium sulfate, per 500 mg 531 413 $724.22
76000 15 13 $708.84
82784 1,195 992 $703.06
91200 20 16 $702.46
82607 587 564 $698.87
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 15 14 $640.78
97116 116 42 $624.12
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,992 1,734 $576.91
J1940 Injection, furosemide, up to 20 mg 505 242 $565.32
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 22 12 $537.38
87205 452 404 $506.56
86704 60 54 $496.79
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 138 81 $490.21
J2250 Injection, midazolam hydrochloride, per 1 mg 4,830 4,328 $487.69
82570 2,262 2,115 $474.97
76642 26 26 $457.46
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 82 64 $443.03
86361 2,072 2,011 $426.47
82043 1,331 1,292 $401.05
J7050 Infusion, normal saline solution, 250 cc 2,448 1,570 $394.59
90739 29 28 $392.68
86593 16 12 $391.52
G0008 Administration of influenza virus vaccine 56 50 $383.11
J2765 Injection, metoclopramide hcl, up to 10 mg 471 403 $373.83
J2370 Injection, phenylephrine hcl, up to 1 ml 1,895 1,700 $349.39
88185 20 19 $346.73
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 859 772 $330.52
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 771 510 $321.73
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 3,723 2,550 $321.14
J1030 Injection, methylprednisolone acetate, 40 mg 116 99 $309.30
82550 1,556 1,381 $299.12
85652 2,084 1,952 $291.48
90480 28 28 $272.87
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,161 1,047 $272.37
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 2,507 1,779 $260.43
84132 2,741 2,224 $253.74
87186 630 532 $238.67
J3370 Injection, vancomycin hcl, 500 mg 35 26 $225.63
94727 43 41 $220.04
94729 33 33 $212.45
85613 137 131 $206.20
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 12 12 $195.93
98966 54 44 $183.92
83540 1,879 1,804 $180.24
85379 876 825 $179.73
84100 4,657 3,237 $172.01
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 1,176 757 $159.70
84156 2,183 2,050 $145.73
86160 299 291 $138.01
85660 501 308 $135.96
84466 1,871 1,793 $131.83
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 37 35 $130.19
82077 212 196 $122.15
83970 976 874 $121.76
85018 33 24 $102.33
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 300 271 $98.67
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 25 25 $94.31
J2060 Injection, lorazepam, 2 mg 217 135 $92.66
87660 26 26 $85.37
98968 13 12 $80.21
J2680 Injection, fluphenazine decanoate, up to 25 mg 185 96 $79.40
84165 806 652 $64.01
90653 15 15 $62.22
J0131 Injection, acetaminophen, not otherwise specified,10 mg 13 12 $61.76
83521 656 504 $45.29
86225 184 182 $41.41
82565 303 253 $37.69
83883 142 131 $32.84
J2550 Injection, promethazine hcl, up to 50 mg 162 129 $29.68
83615 471 374 $23.42
J7510 Prednisolone oral, per 5 mg 19 14 $20.49
88313 12 12 $19.84
84295 467 382 $19.08
84550 1,164 1,018 $18.98
80164 14 12 $12.22
82465 77 76 $7.80
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 892 845 $2.70
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 441 424 $0.03
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 30 26 $0.01
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 16 14 $0.01
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 14 14 $0.00
G1012 Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program 3,420 2,586 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 476 441 $0.00
96417 1,332 839 $0.00
84403 16 15 $0.00
0054A 85 85 $0.00
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg 16 12 $0.00
86334 12 12 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 79 74 $0.00
82248 12 12 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 53 49 $0.00
0002A 60 53 $0.00
A4649 Surgical supply; miscellaneous 29 26 $0.00
J1453 Injection, fosaprepitant, 1 mg 20 12 $0.00
93356 25 24 $0.00
87075 32 24 $0.00
82542 56 55 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 30 30 $0.00
90853 Group psychotherapy (other than of a multiple-family group) 75 25 $0.00
J1171 Injection, hydromorphone, 0.1 mg 28 13 $0.00
88173 13 12 $0.00
G8990 Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals 15 14 $0.00
84154 12 12 $0.00
86769 52 51 $0.00
J0613 Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg 81 73 $0.00
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml 203 132 $0.00
88342 306 280 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 403 392 $0.00
87430 12 12 $0.00
88184 21 20 $0.00
80220 14 14 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 47 40 $0.00
96376 56 42 $0.00
0001A 111 107 $0.00
80069 13 13 $0.00
90656 144 144 $0.00
36000 13 12 $0.00
88341 12 12 $0.00
J0611 Injection, calcium gluconate (wg critical care), per 10 ml 16 13 $0.00
82378 13 13 $0.00
86255 17 16 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 12 12 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 48 40 $0.00
G8991 Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 16 14 $0.00
0012A 14 14 $0.00